ID: ALA4781939
Chembl Id: CHEMBL4781939
PubChem CID: 162665095
Max Phase: Preclinical
Molecular Formula: C24H18FNO2
Molecular Weight: 371.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: OCc1c(CO)c2c3ccccc3c3ccccc3n2c1-c1ccc(F)cc1
Standard InChI: InChI=1S/C24H18FNO2/c25-16-11-9-15(10-12-16)23-20(13-27)21(14-28)24-19-7-2-1-5-17(19)18-6-3-4-8-22(18)26(23)24/h1-12,27-28H,13-14H2
Standard InChI Key: BODQHTROELSLDZ-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 371.41 | Molecular Weight (Monoisotopic): 371.1322 | AlogP: 5.04 | #Rotatable Bonds: 3 |
| Polar Surface Area: 44.87 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.79 | CX LogD: 3.79 |
| Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.44 | Np Likeness Score: -0.28 |
| 1. Patel AS,Jain V,Rao VN,Lin YW,Shah A,Lai KC,Su TL,Lee TC. (2020) Design, synthesis and antitumour evaluation of pyrrolo[1,2-f]-phenanthridine and dibenzo[f,h]pyrrolo[1,2-b]isoquinoline derivatives., 202 [PMID:32622270] [10.1016/j.ejmech.2020.112516] |
Source(1):
